FOSAMPRENAVIR vs FOSTAMATINIB: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
FOSAMPRENAVIR vs FOSTAMATINIB: Safety Overview
| Metric | FOSAMPRENAVIR | FOSTAMATINIB |
|---|---|---|
| Total FAERS Reports | 460 | 6,394 |
| Deaths Reported | 31 | 453 |
| Death Rate | 6.7% | 7.1% |
| Hospitalizations | 91 | 1,493 |
| Average Patient Age | 45.3 yrs | 64.7 yrs |
| % Female Patients | 27.9% | 60.8% |
| FDA Approval Date | Apr 15, 2016 | Apr 17, 2018 |
| Manufacturer | Sun Pharmaceutical Industries, Inc. | Rigel Pharmaceuticals, Inc. |
| Route | ORAL | ORAL |
| Marketing Status | Discontinued | Prescription |